Skip to main content
. 2019 Mar 22;17(5):4249–4258. doi: 10.3892/etm.2019.7427

Table I.

Characteristics of patients included in the present study.

Characteristic Aflibercept (n=40) Ranibizumab (n=40) P-value
Sex
  Male 17 (42.5) 19 (47.5) >0.05
  Female 23 (57.5) 21 (52.5)
Age (years) 60.5±4.3 62.4±7.1 0.15
Course of disease (months) 39.5±9.2 43.5±13.2 0.12

Values are expressed as n (%) or mean ± standard deviation.